Mental health hospitalizations associated with sustained extreme heat in multiple countries - Nature

IntroductionClimate change is resulting in an increasing frequency of heatwaves, which leads to a substantial increase in deaths and hospitalizations in the summer1. Besides heat, cold continues to be a major health threat and accounts for substantial proportions of deaths2 and hospitalizations3,4. Current evidence suggests heat to be associated with more hospitalizations due to infectious diseases, respiratory, cardiovascular, and neurological outcomes5,6,7, while cold temperatures were primarily associated with cardiovascular and respiratory conditions8. Compared to mortality, hospitalizations reflect a more sensitive indicator of temperature-related health effects, including also less severe cases. Moreover, temperature-related (emergency) hospitalizations are of central public health importance since they naturally reflect unplanned admissions, reveal vulnerabilities in the population, and thus represent a source of uncertainty and potential strain on existing hospital capacity.

Patients with schizophrenia and type 2 diabetes on GLP-1 receptor agonists were less likely to require acute psychiatric care, such as hospital visits, compared with those using other diabetes drugs such as DPP-4 or SGLT2 inhibitors, according to a new peer-reviewed study. The study published on Wednesday in the Lancet Psychiatry journal was based on electronic health record data representing more than 70,200 adults with schizophrenia and T2D who were receiving diabetes therapy between Jan. 1, 2018, and Oct. 1, 2025According to its authors, patients on GLP-1 agonists had a 24% lower risk of undergoing psychiatric hospitalizations compared with those who were not treated for diabetes and an 18% and 17% lower risk compared with those who were on DPP-4 and SGLT2 inhibitors, respectively. Lead investigator Najmeh Davoodian, an associate research fellow at Deakin University in Australia, said that the results marked the first to show a connection between schizophrenia hospitalizations and GLP-1s, a popular drug class marketed by Novo Nordisk NVO and Lilly LLY.

TMZ has revealed details of the prison fight that landed Sean “Diddy” Combs in the hospital with a head injury over the weekend. According to a new report, the disgraced rap mogul and a Jamaican drug lord named “Dudus” got into the altercation on Friday, October 9th, after a recent NBC News exposé about Diddy’s lavish prison lifestyle led to inmates’ illicit privileges being taken away.

PRIMA implantation was associated with sustained visual acuity improvement from approximately 20/460 to 20/120 at 36 months Among 18 patients evaluated at 3 years, 78% achieved gains of at least 3 lines of visual acuity